media – Page 586 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

The Top 3 Digital Health Trends to Watch In 2018

Digital health broke out in 2017. We saw more investment than ever before: Over $4.7 billion flowed into a record number of companies. While these record-breaking investments underscore the enthusiasm for new digital health solutions, another revolution was quietly happening just outside the spotlight.
- Source: fortune
- 614
- December 21, 2017
digital health Researches Telemedicine
AbbVie Scores Key Trial Win for RA Drug With One Fatal Event Reported

AbbVie’s investigational JAK1-inhibitor upadacitinib yielded positive top-line results in a Phase III trial as a monotherapy for rheumatoid arthritis patients. But the drug shows that it is still plagued by some safety concerns.
- Source: Biospace
- 577
- December 21, 2017
Clinical Trials inhibitor Phase rheumatoid arthritis
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active Psoriatic Arthritis

XELJANZ/XELJANZ XR, THE FIRST ORAL JAK INHIBITOR IN THE U.S. FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS, IS NOW APPROVED FOR ADULTS WITH ACTIVE PSORIATIC ARTHRITIS
- Source: Pfizer
- 520
- December 21, 2017
DMARDs New Approvals rheumatoid arthritis XELJANZ
Triple drug treatment combo shows promise in adult leukemia

A triple-drug focused remedy method may provide an efficient new treatment choice for power lymphocytic leukemia (CLL) that reduces the chance for the lengthy-time period unintended effects skilled with chemotherapy and is given for a restricted time, not as a day by day lifetime drug remedy.
- Source: medical-newspaper
- 579
- December 21, 2017
Chemotherapy diabetes Researches triple-drug
How an active social life could lower diabetes risk

New European research has found that a good social life could lower the risk of developing type 2 diabetes and pre-diabetes.
- Source: msn
- 524
- December 21, 2017
Researches social life type 2 diabetes
4 Tips for Purchasing Medical Devices

Over the past decade, the medical device industry has seen a boom in development and innovative ideas. With this innovation came a rise in the costs of medical device products which presents new challenges to buyers. With this in mind, we have compiled a list of 4 tips that could help you in this decision making process.
- Source: Ddu
- 804
- December 21, 2017
Ddu College medical device
Nanoparticle-Based Imaging of Metastasis Throughout Body

Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go
- Source: medgadget
- 866
- December 20, 2017
breast cancer MRI Researches tumor
Medical Devices Exploring the Impact of the New European Directive on the Pharmaceutical Industry

Pedro Pala, Clinical Trial Supply Manager, Bial, explores the implications of the new EU Clinical Trials Regulation
- Source: clinicaltrialsarena
- 960
- December 20, 2017
Directive EU polices
Surgery of the future

First of all, a 3D model of the patient was been created before surgery, combining images previously acquired via an MRI scanner, or radiography. On the day of the operation, a 3D image was (virtually) projected on the patient, and helped Dr Grégory in any of his movements and decision making.
- Source: leyton
- 705
- December 20, 2017
Researches Surgery of the future
Silencing ‘junk’ gene could halt tumor growth

The gene is in an area of the genome that does not contain instructions for making proteins. At one time, it was thought that this non-coding area was just irrelevant "junk."
- Source: Medicalnewstoday
- 534
- December 20, 2017
cancer Researches tumor

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.